Autopsy report · NCT00948025
A Comparative Post-marketing Study of Commercially Available Peripheral Nerve Gap Repair Options
Cause of deathOther
“transitioning from 361 HCT/P Tissue to a Biologic (BLA)”
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 5 years 6 months before it stopped.
- 23 participants enrolled.
- Results were posted on the registry 6 years after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Axogen Corporation
- Sponsor type
- Industry
- Conditions
- Traumatic Nerve Injury
- Interventions
- Hollow tube nerve conduit, synthetic or biosynthetic; Processed Human Nerve Tissue
- Participants
- 23
- Sites
- 4
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.